Artiva CEO granted 110K RSUs, 315K options
Artiva Biotherapeutics’ CEO received new stock and option grants, raising his direct common share holdings.
Rhea-AI Filing Summary
Artiva Biotherapeutics, Inc. (ARTV) reported that Chief Executive Officer Fred Aslan received new equity awards on September 15, 2026. He was granted 110,000 shares of Common Stock as a restricted stock unit award under the company’s 2024 Equity Incentive Plan, increasing his direct Common Stock holdings to 1,604,765 shares after the grant.
He was also granted an option to acquire 315,000 shares of Common Stock at an exercise price of $8.91 per share, expiring September 14, 2036. Beginning on September 8, 2026, 1/48th of the option shares will vest in equal monthly installments over four years. No Rule 10b5-1 trading plan is reported for these awards.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 425,000 shares
Grant/Award
2 txns
Insider
Aslan Fred
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) F2 | 315,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 110,000 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 315,000 contracts (Direct);
Common Stock — 1,604,765 shares (Direct)
Footnotes (2)
- F1. Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.
- F2. Beginning on September 8, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four-year period.
Key Figures
Restricted Stock Unit award: 110,000 shares of Common Stock
Option grant: 315,000 option shares
Option exercise price: $8.91 per share
+3 more
6 metrics
Restricted Stock Unit award
110,000 shares of Common Stock
Granted to the CEO on September 15, 2026 under the 2024 Equity Incentive Plan
Option grant
315,000 option shares
Employee Stock Option (Right to Buy) granted on September 15, 2026
Option exercise price
$8.91 per share
Exercise price for the 315,000-share option grant
Shares held after RSU grant
1,604,765 shares
CEO’s direct Common Stock holdings after the 110,000-share RSU award
Option expiration date
September 14, 2036
Expiration date of the 315,000-share option grant
Option vesting schedule
1/48th monthly over 4 years
Vesting begins September 8, 2026, in equal monthly installments
Key Terms
Restricted stock unit, Equity Incentive Plan, Exercise price, Expiration date
4 terms
Restricted stock unit financial
"Represents restricted stock unit award granted under the Issuer's 2024 Equity"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Equity Incentive Plan financial
"restricted stock unit award granted under the Issuer's 2024 Equity Incentive"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
Exercise price financial
"option to acquire 315,000 shares of Common Stock at an exercise price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Expiration date financial
"option for 315,000 shares has an expiration date of September 14, 2036"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did ARTV grant to its CEO Fred Aslan on September 15, 2026?
Fred Aslan received a restricted stock unit award of 110,000 Common Stock shares and an option to purchase 315,000 Common Stock shares at $8.91 per share, both granted on September 15, 2026, under Artiva Biotherapeutics’ 2024 Equity Incentive Plan.
What are the key terms of the new stock option granted by ARTV to its CEO?
The CEO received an option for 315,000 shares of Artiva Biotherapeutics Common Stock at an exercise price of $8.91 per share, with an expiration date of September 14, 2036. The option covers 315,000 underlying Common Stock shares.
How does the vesting schedule work for the CEO’s new ARTV stock option?
Beginning on September 8, 2026, 1/48th of the 315,000 option shares will vest each month in equal installments over a four-year period, as disclosed in the footnote to the option award.
Was the ARTV CEO’s equity award made under a Rule 10b5-1 trading plan?
No. The Form 4 indicates the document-level Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that these equity awards were made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
